Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, September 24, 2024
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
[ Tue, Sep 24th 2024
] - WOPRAI
Robert Burns Reiterated (BDTX) at Strong Buy and Held Target at $11 on, Sep 24th, 2024
Robert Burns of HC Wainwright & Co., Reiterated "Black Diamond Therapeutics, Inc." (BDTX) at Strong Buy and Held Target at $11 on, Sep 24th, 2024.
Robert has made no other calls on BDTX in the last 4 months.
There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Joseph Catanzaro of "Piper Sandler" Maintained at Buy with Increased Target to $15 on, Monday, September 23rd, 2024
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $16 on, Tuesday, September 10th, 2024
- Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024
